Fellowship · Little Rock, AR
Sponsored by University of Arkansas for Medical Sciences (UAMS) College of Medicine
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
The Lancet. Respiratory medicine · 2023 · 109 citations · Ariel Berlinski
Aerosol therapy in adult critically ill patients: a consensus statement regarding aerosol administration strategies during various modes of respiratory support.
Annals of intensive care · 2023 · 51 citations · Ariel Berlinski
PRenatal mOdulator treatment to PrEvent CF complicaTions (PROTECT) workshop report.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2025 · 19 citations · Jennifer Guimbellot
Long term clinical effectiveness of ivacaftor in people with the G551D CFTR mutation.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021 · 59 citations · Jennifer Guimbellot
Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipients.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2022 · 42 citations · Jennifer Guimbellot
Epidemiology of Biofilm Producing Acinetobacter baumannii Nosocomial Isolates from a Tertiary Care Hospital in Egypt: A Cross-Sectional Study.
Infection and drug resistance · 2021 · 36 citations · Samah Awad
Progenitor potential of lung epithelial organoid cells in a transplantation model.
Cell reports · 2022 · 48 citations · Erhan Ararat
Electronic screening for unmet social needs in a pediatric pulmonary clinic: Acceptability and associations with health outcomes.
Pediatric pulmonology · 2023 · 14 citations · Jennifer Guimbellot